Skip to Content

Join the 'Zelnorm' group to help and get support from people like you.

Zelnorm News

FDA Medwatch Alert: Zelnorm (tegaserod maleate)

Posted 30 Mar 2007 by Drugs.com

[Posted 03/30/2007] FDA notified healthcare professionals and patients that Novartis has agreed to discontinue marketing Zelnorm, a drug used for the short-term treatment of women with irritable bowel syndrome with constipation and for patients younger than 65 years of age with chronic constipation. FDA analysis of safety data pooled from 29 clinical trials involving over 18,000 patients showed ...

FDA Medwatch Alert: Zelnorm (tegaserod maleate)

Posted 28 Apr 2004 by Drugs.com

The FDA and Novartis notified healthcare professionals of an important drug warning and prescribing information for Zelnorm, a serotonin 5-HT4 receptor partial agonist indicated for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation. This new information relates to a Warning for serious consequences of diarrhea and a Precaution for ...

Ask a Question

Further Information

Related Condition Support Groups

Constipation - Chronic, Irritable Bowel Syndrome

Zelnorm Patient Information at Drugs.com